Hormonal Control of Peripheral Resistance

Hormonal Control of Peripheral Resistance is the modulation of systemic arteriolar tone by circulating hormones, principally angiotensin II and vasopressin acting as vasoconstrictors and natriuretic peptides acting as vasodilators, operating alongside and reinforcing the faster sympathetic neural control of resistance described under Autonomic Control of Peripheral Resistance. Because these hormones circulate systemically and can influence essentially any vascular bed expressing the relevant receptors, hormonal control provides a broader, more diffusely distributed layer of resistance regulation that complements the more regionally selective pattern characteristic of sympathetic innervation.

Hormonal Vasoconstrictors

Angiotensin II

Angiotensin II acts on AT1 receptors throughout the systemic vasculature to produce direct, potent vasoconstriction, as detailed under Angiotensin II Vascular Effect, contributing meaningfully to total peripheral resistance particularly during states of activated renin-angiotensin-aldosterone system function, such as hemorrhage, dehydration, or chronic hypertension.

Vasopressin

At the elevated concentrations achieved during severe hypovolemia or hypotension, vasopressin acts on V1 receptors to produce additional vasoconstriction, as detailed under Antidiuretic Hormone Vascular Effect, functioning as a reserve resistance-supporting mechanism engaged specifically when circulatory stress is severe enough to drive vasopressin well above its osmoregulatory concentration range.

Where total peripheral resistance at any moment reflects the combined, partly overlapping contributions of sympathetic neural tone and multiple hormonal vasoconstrictors, reduced by the opposing vasodilatory contribution of natriuretic peptides, illustrating the multi-system nature of overall resistance determination.

The Opposing Hormonal Vasodilator

Natriuretic Peptides

Natriuretic peptides act through the NPR-A/cyclic GMP pathway described under Natriuretic Peptide Vascular Effect to produce direct vasodilation, opposing the vasoconstrictor hormones above and contributing a hormonal counterbalance that becomes particularly relevant during states of cardiac volume or pressure overload that trigger their release.

Net Resistance as a Balance of Opposing Signals

Because vasoconstrictor and vasodilator hormonal signals can be simultaneously present, particularly in conditions such as heart failure where both the renin-angiotensin-aldosterone system and natriuretic peptides are activated, the net effect on peripheral resistance reflects the relative balance and receptor sensitivity of these opposing pathways rather than the unopposed action of either system alone.

Comparison with Neural Control

Broader, Less Regionally Selective Distribution

Whereas sympathetic vasoconstrictor tone is regionally differentiated, dense in splanchnic, renal, and cutaneous beds while comparatively sparse in cerebral and coronary circulation, circulating hormonal vasoconstrictors can act on any vascular bed expressing the relevant receptor, producing a more broadly distributed, though not entirely uniform, resistance effect across the vasculature.

Slower Onset, More Sustained Duration

Hormonal control of resistance generally has a slower onset than neural control, reflecting the time required for hormone synthesis, release, and circulation to target tissues, but tends to produce more sustained resistance changes, particularly relevant for maintaining elevated resistance over the extended periods, hours to days, during which ongoing volume or pressure challenges may persist beyond what fast neural mechanisms alone can indefinitely sustain.

Interaction with Local Vascular Regulation

Modulation Rather Than Override of Local Autoregulation

Hormonal vasoconstrictors and vasodilators act upon, rather than eliminate, the local metabolic and myogenic autoregulatory mechanisms operating within each vascular bed, meaning tissues with strong local vasodilatory drive, such as actively exercising skeletal muscle, can partially resist hormonal vasoconstriction through mechanisms analogous to the functional sympatholysis described under Sympathetic Control of Arteriolar Tone.

Preferential Preservation of Critical Organ Flow

As with neural vasoconstrictor control, cerebral and coronary circulation retain relatively robust local autoregulatory capacity that helps preserve flow to these organs even during substantial hormonally driven increases in resistance elsewhere, consistent with the priority pattern described in Regional Flow Competition Pattern.

Clinical Relevance

Pharmacological Targeting Across Multiple Hormonal Pathways

Angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, vasopressin receptor antagonists, and neprilysin inhibitors each modulate a distinct hormonal contributor to peripheral resistance, providing multiple, mechanistically distinct pharmacological approaches to managing hypertension and heart failure by targeting this hormonal layer of resistance control specifically.

Distributive Shock and Hormonal Resistance Support

In severe distributive shock, exogenous vasopressin and, less commonly, angiotensin II infusions are used clinically to directly augment hormonally mediated peripheral resistance when endogenous sympathetic and hormonal mechanisms alone are insufficient to maintain adequate arterial pressure, directly applying the pathways described here at pharmacological concentrations.